Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Initio Cell
Leiden, Netherlands
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
01
Overview
Initio Cell has commercially launched several organ-on-chip products (IC-Chip, DDI-Chip, DR-Chip) for preclinical drug research and diagnostic development, providing CRO services but does not directly develop therapeutics; thus, it does not report clinical trial results.
- Therapeutic areas
- OncologyInfectious DiseasesOther
- Modalities
- DeviceMicrophysiological systemOrgan-on-chip device
- Industry
- Non-Drug Biotech
02
Partnerships
Institute for Human Organ and Disease Model Technologies (hDMT)Regenerative Medicine Crossing Borders (RegmedXB)Leiden Bio Science Park academic collaborations
Beyond the preview
Go deeper on Initio Cell.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Initio Cell.